DiscoverEndpointsNurOwn and the Hope for Stem Cells in ALS?
NurOwn and the Hope for Stem Cells in ALS?

NurOwn and the Hope for Stem Cells in ALS?

Update: 2019-09-04
Share

Description

On this episode of the Endpoints, Dr. Steve Perrin, CEO at ALS TDI answers questions about one of the most talked about clinical trials in ALS at the moment, Brainstorm Cell Therapeutics’ NurOwn, a proposed stem-cell-based treatment. The therapy focuses on the cellular support system around a person with ALS’ motor neurons. It aims to slow disease progression by replacing the damaged system with an enhanced one.


Access more episodes of the Endpoints Podcast.

Support the show.

Comments 
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

NurOwn and the Hope for Stem Cells in ALS?

NurOwn and the Hope for Stem Cells in ALS?

ALS TDI